Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.

European journal of public health - 4 Aug 2026

Leino Aarno, Numminen Eero, Fonagy Veronika, Paloniemi Minna, Seiskari Tapio, Kholová Ivana, Kares Saara, Louvanto Karolina

Abstract excerpt

High-risk human papillomavirus (HR-HPV) screening effectively reduces cervical cancer incidence, but limited specificity leads to excessive colposcopy referrals. Extended HR-HPV genotyping improves triage by accounting for genotype-specific oncogenic risks, offering a more precise framework for patient management than traditional pooled testing. This study analysed real-world screening data from a Finnish cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Finland

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human Papillomavirus Viruses

Share to Incidence

Share to Mass Screening

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 42606565
DOI: 10.1093/eurpub/ckag139
PMCID: PMC13479743

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.PMID 42606565Read ↗

Clinical relevance of partial HPV genotyping in cervical cancer screening.Semantic proximity Read ↗

Improving Efficiency in Dutch Cervical Screening by Genotyping: An Analysis of Real World Program Data.Semantic proximity Read ↗

Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.Semantic proximity Read ↗

Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytologySemantic proximity Read ↗

The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology.Semantic proximity Read ↗

The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.Semantic proximity Read ↗

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening.Semantic proximity Read ↗

A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.Semantic proximity Read ↗

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology ResultsSemantic proximity Read ↗

Accelerating Cervical Cancer Screening With Human Papillomavirus Genotyping.Semantic proximity Read ↗

Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesionsSemantic proximity Read ↗

High-Risk Human Papillomavirus Prevalence and Genotype Distribution in Two Opportunistic Cervical Screening Periods in Spain: A Tertiary Hospital-Based Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.